시장보고서
상품코드
2050893

체외진단(IVD) 시장 : 제품 유형별, 검사 유형별, 용도별, 최종사용자별, 지역별

In Vitro Diagnostics Ivd Market, By Product, By Test Type, By Application, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,933,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,785,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,408,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

체외진단(IVD) 시장은 2026년에 1,352억 2,000만 달러로 추정되며, 2033년까지 2,129억 1,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.7%를 기록할 전망입니다.

보고서 범위 보고서 상세
기준 연도 : 2025년 2026년 시장 규모 : 1,352억 2,000만 달러
과거 데이터 기간 : 2020-2024년 예측 기간 : 2026-2033년
예측 기간(2026-2033년) CAGR : 6.70% 2033년 시장 규모 예측 : 2,129억 1,000만 달러

세계 체외진단(IVD) 시장은 혈액, 소변, 조직 등 생체 시료를 검사하여 질병을 진단하는 시장입니다. IVD 기술은 질병의 조기 발견을 가능하게 하여 적절한 시기에 임상적 개입과 환자의 예후를 개선할 수 있습니다. 시장 성장은 고령 인구 증가, 만성 질환 및 감염성 질환의 유병률 증가, 보다 정확한 현장 검사 및 분자진단 검사의 개발로 이어지는 기술 발전에 의해 주도되고 있습니다. 그러나 신제품 승인에 대한 엄격한 규제와 일부 국가의 불리한 의료제도 개혁이 시장 성장을 저해하고 있습니다.

시장 역학

세계 체외진단 시장의 성장은 만성질환에 취약한 고령 인구 증가, 암, 당뇨병 등 생활습관병 발병률 증가, 질병 조기 발견에 대한 인식이 높아짐에 따라 성장세를 보이고 있습니다. 기술의 발전으로 인해 현장 진료 및 재택 검사를 위한 소형화, 휴대형 진단 플랫폼이 개발되고 있으며, 이는 주요 성장 요인 중 하나입니다. 그러나 신규 진단 제품 승인에 대한 엄격한 규제 지침과 일부 지역의 의료 보험 적용 범위 축소로 인해 시장 성장에 위협이 되고 있습니다. 또한, 국가마다 첨단 분자진단 검사에 대한 상환 정책이 달라 시장 성장을 저해하는 요인으로 작용하고 있습니다. 신흥국의 의료비 증가는 유망한 비즈니스 기회를 제공합니다.

본 조사의 주요 특징

  • 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
  • 이 연구는 다음과 같은 매개 변수를 기반으로 세계 체외 진단 의약품 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
  • 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
  • 세계 체외 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 체외진단제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 체외진단(IVD) 시장 : 제품별, 2021년-2033년

제5장 세계의 체외진단(IVD) 시장 : 테스트 유형별, 2021년-2033년

제6장 세계의 체외진단(IVD) 시장 : 용도별, 2021년-2033년

제7장 세계의 체외진단(IVD) 시장 : 최종사용자별, 2021년-2033년

제8장 세계의 체외진단(IVD) 시장 : 지역별, 2021년-2033년

제9장 경쟁 구도

제10장 애널리스트의 견해

제11장 참고 문헌 및 조사 방법

LSH 26.06.15

In Vitro Diagnostics Ivd Market is estimated to be valued at USD 135.22 Bn in 2026 and is expected to reach USD 212.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 135.22 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.70% 2033 Value Projection: USD 212.91 Bn

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Reagents & Kits
  • Instruments
  • Test Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Clinical Chemistry
  • Immunoassay
  • Hematology
  • Molecular Diagnostics
  • Microbiology
  • Coagulation & Hemostasis
  • Urinalysis
  • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disorders
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Siemens Healthineers
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • bioMerieux S.A.
  • Becton Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • F. Hoffmann-la Roche Ltd
  • QIAGEN N.V.
  • Arkray Inc.
  • Nittobo Medical Co. Ltd.
  • Medical & Biological Laboratories Co. Ltd.
  • Miraca Holdings Inc.
  • Mizuho Medy Co. Ltd.
  • Thermo Fischer Scientific Inc
  • Diasorin
  • Agilent Technologies, Inc
  • Grifols SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Test Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • PEST Analysis

4. Global In-Vitro Diagnostics Market, By Product, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Reagents & Kits
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Instruments
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global In-Vitro Diagnostics Market, By Test Type, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Clinical Chemistry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Immunoassay
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Hematology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Molecular Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Microbiology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Coagulation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Application, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Infectious Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Diabetes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Cardiology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Nephrology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Autoimmune Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By End User, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Diagnostic Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Academic & Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By Region, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • bioMerieux S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton Dickinson, and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-la Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arkray, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nittobo Medical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medical & Biological Laboratories Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Miraca Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mizuho Medy Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fischer Scientific Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Diasorin
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Agilent Technologies, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Grifols SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기